Institutt for farmasi
Engelsk personkortArbeider i CRIStin
- Håkonsen, Gro Dahlseng; Pettersen, Merethe Harjo; Skurtveit, Svetlana; Giverhaug, trude. Samtidig bruk av warfarin, analgetika og antiinflammatoriske midler. Tidsskrift for Den norske legeforening 2009; Volum 129 (12). ISSN 0029-2001.s 1217 - 1220.
- Håkonsen, Gro Dahlseng; Strelec, Petra; Campbell, Derna; Hudson, Steve; Loennechen, Thrina. Adherence to medication guideline criteria in cancer pain management. Journal of Pain Symptom and Management 2009; Volum 37 (6). ISSN 0885-3924.s 1006 - 1018.
- Håkonsen, Gro Dahlseng; Torbergsen, Ann Lisbeth; Strelec, Petra; Campbell, Derna; Hudson, Steve; Loennechen, Thrina. A medication assessment tool to evaluate adherence to medication guideline criteria in cancer pain management. International Journal of Pharmacy Practice 2008; Volum 16 (2). ISSN 0961-7671.s 99 - 107.
- Håkonsen, Gro Dahlseng; Hudson, Steve; Loennechen, Thrina. Design and validation of a medication assessment tool for cancer pain management. Pharmacy World & Science 2006; Volum 28 (6). ISSN 0928-1231.s 342 - 351.s doi: 10.1007/s11096-006-9060-4.
- Håkonsen, Gro Dahlseng; Dreischulte, T; Hudson, Steve. Evaluating and improving the rational use of medicines in individual patients, targeted groups and populations. Pharmacy World & Science 2010; Volum 32 (2). ISSN 0928-1231.s 253 - 254.
- Håkonsen, Gro Dahlseng; Strelec, P; Campbell, D; Hudson, Steve; Loennechen, Thrina. Adherence to medication guideline criteria in cancer pain management. Pharmacy World & Science 2010; Volum 32 (2). ISSN 0928-1231.s 252 - 252.
- Håkonsen, Gro Dahlseng; Strelec, Petra; Campbell, Derna; Hudson, Steve; Loennechen, Thrina. Adherence to medication guideline criteria in cancer pain management. ESCP-GSASA Symposium, Geneva, 3-6 November 2009 2009-11-03 - 2009-11-06 2009.
- Dreischulte, Tobias; Håkonsen, Gro Dahlseng; Hudson, Steve. Assessment of appropriate prescribing using medication guideline criteria. ESCP-GSASA Symposium, Geneva, 3-6 November 2009 2009-11-03 - 2009-11-06 2009.
- Håkonsen, Gro Dahlseng. Samtidig bruk av warfarin, analgetika og antiinflammatoriske midler. 2009.
- Torbergsen, Ann Lisbeth; Håkonsen, Gro Dahlseng; Hudson, Steve; Loennechen, Thrina; Campbell, Derna. Evaluation of an assessment tool for adherence to medication guideline criteria in cancer pain management. Pharmacy World & Science 2009; Volum 31 (1). ISSN 0928-1231.s 85 - 86.
- Torbergsen, Ann Lisbeth; Håkonsen, Gro Dahlseng; Hudson, Steve; Loennechen, thrina; Campbell, Derna. Evaluation of an assessment tool for adherence to medication guideline criteria in cancer pain management. ESCP’s 7th Spring Conference on Clinical Pharmacy. Tackling inequalities in the delivery of pharmaceutical care 2007-05-16 - 2007-05-19 2007.
- Håkonsen, Gro Dahlseng; Loennechen, Thrina. Bruk av et verktøy for å evaluere behandling av kreftsmerte. Norsk Farmaceutisk Tidsskrift 2007; Volum 115 (2). ISSN 0029-1935.s 27 - 28.
- Håkonsen, Gro Dahlseng. Kvalitetssikring av smertebehandling ved kreftsykdom. Bruk av et verktøy for å evaluere behandling. Medikamentell smertebehandling ved kreftsykdom, VETT 2007-02-13 - 2007.
- Håkonsen, Gro Dahlseng. Care issues in the management of malignant pain. The development and validation of a novel Medication Assessment Tool. 2007 ISBN 978-82-497-0302-9.
- Håkonsen, Gro Dahlseng; Hudson, Steve; Loennechen, Thrina. Design and validation of the Norwegian Medication Assessment Tool for Cancer Pain Management (MAT-CP). ESCP’s 6th Spring Conference on Clinical Pharmacy. Chronic disease management: the role of the pharmacist 2006-05-25 - 2006-05-27 2006.
- Håkonsen, Gro Dahlseng; Loennechen, Thrina. Bruk av et verktøy for å evaluere behandling av kreftsmerte. Farmasidagene 2006-10-26 - 2006-10-28 2006.
- Håkonsen, Gro Dahlseng; Nordøy, Tone; Loennechen, Thrina. Pain management in cancer patients: A pilot study. NSFT vintermøte 2005 2005-01-27 - 2005-01-30 2005.
- Håkonsen, Gro Dahlseng; Brandl, Martin; Massing, U.. Development and validation of a high performance liquid chromatographic assay for the determination of gemcitabine (dFdC) and its metabolite dFdU in human plasma. 2002.
